Clinical Trial Update: Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Previfenon as chemoprophylaxis of COVID-19 in health workers, currently in Phase 2/Phase 3 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Drugs mentioned

• Previfenon

Snippet

Sponsor: MELISA Institute Genomics & Proteomics Research SpA | Conditions: COVID-19, SARS-CoV2 | Phase 2, Phase 3 | Status: UNKNOWN